NeuroFuse System / e-TLIF Procedure
Chronic low back and leg pain in patients undergoing lumbar spinal fusion
FeasibilityActive
Key Facts
Indication
Chronic low back and leg pain in patients undergoing lumbar spinal fusion
Phase
Feasibility
Status
Active
Company
About SynerFuse
SynerFuse is a private, pre-revenue medical device innovator targeting the significant unmet need for chronic pain management in spinal fusion patients. The company has developed the NeuroFuse System, an implantable pulse generator and lead system designed to be implanted concurrently with fusion hardware to provide direct nerve stimulation. Having completed a 15-patient proof-of-concept feasibility study under an FDA IDE, the company is positioned to advance its integrated therapy. It aims to improve surgical outcomes, reduce post-operative opioid reliance, and lower the overall economic burden of chronic back pain.
View full company profile